{"title":"In vitro NAD+ supplementation increases CD4+ and CD8+ T cell function in people with HIV.","authors":"Guangming Li, Salma Sharaf, Yaoxian Lou, Lishan Su, Shyam Kottilil, Poonam Mathur","doi":"10.1111/hiv.70342","DOIUrl":"https://doi.org/10.1111/hiv.70342","url":null,"abstract":"<p><strong>Objectives: </strong>HIV perturbs T cell homeostasis and disrupts immune function, increasing the risk of age-associated comorbidities. Ageing people with HIV (PWH) have exacerbated expression of CD38 on T cells, which depletes intracellular nicotinamide adenine dinucleotide (NAD+). We investigated whether boosting intracellular NAD+ could restore T cell homeostasis and function.</p><p><strong>Methods: </strong>We collected blood samples from virally suppressed PWH to determine the effects of in vitro NAD+ on CD38 expression and T cell function in response to anti-CD3/CD28 antibodies stimulation in PBMCs culture supplemented with IL-2 and IL-7.</p><p><strong>Results: </strong>We observed that NAD+ supplementation not only reduced expression of CD38 but also improved T cell function with an alleviated exhaustion phenotype in response to anti-CD3/CD28 antibodies stimulation.</p><p><strong>Conclusions: </strong>If confirmed in clinical trials, NAD+ supplementation has the potential to restore T cell homeostasis and immune function in PWH and ameliorate age-associated comorbidities.</p>","PeriodicalId":13176,"journal":{"name":"HIV Medicine","volume":" ","pages":""},"PeriodicalIF":3.2,"publicationDate":"2026-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149320726","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
HIV MedicinePub Date : 2026-11-02Epub Date: 2026-09-24DOI: 10.1111/hiv.70311
Cian Dowling-Cullen, Katie O'Brien, Kate O'Donnell, Mary Archibald, Phil Downes, David Field, Caroline Hurley, Fiona Lyons, Eavan Muldoon, Peter Barrett, Cathal Walsh, Derval Igoe
{"title":"Late HIV diagnosis: An application of flexible Bayesian approaches to understand associated factors and time to diagnosis in Ireland, 2015–2024","authors":"Cian Dowling-Cullen, Katie O'Brien, Kate O'Donnell, Mary Archibald, Phil Downes, David Field, Caroline Hurley, Fiona Lyons, Eavan Muldoon, Peter Barrett, Cathal Walsh, Derval Igoe","doi":"10.1111/hiv.70311","DOIUrl":"10.1111/hiv.70311","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>Late HIV diagnosis is associated with increased morbidity, mortality and onward transmission. The proportion diagnosed late reflects the combined effects of testing delays, incidence and migration, complicating its interpretation. We analysed national HIV surveillance data for Ireland (2015–2024) to understand the factors associated with late HIV diagnosis and testing delays.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We estimated prevalence ratios (PRs) for late diagnosis among new diagnoses using Bayesian logistic regression with marginal standardization. We investigated testing delays by estimating infection times and modelling truncation-adjusted delay distributions with Bayesian lognormal regression. We conducted several sensitivity analyses for the main findings.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Among 1551 included new HIV diagnoses with available information, 684 (44.1%) were late. This proportion exceeded 50% in several subgroups, including people aged over 50 years, people whose probable mode of transmission was heterosexual contact, and people born in sub-Saharan Africa. Increasing age (adjusted PR per decade 1.20; 95% credible interval [CrI] 1.15–1.26) and heterosexual transmission (adjusted PR for heterosexual men vs. sex between men 1.43; 95% CrI 1.23–1.67) were associated with late diagnosis in both univariable and multivariable models. For in-Ireland infections, median time from infection to diagnosis was estimated at 1.94 years (95% CrI 1.36–3.40), though this was particularly sensitive to modelling assumptions assessed in our sensitivity analyses, and the multivariable findings suggested longer time to diagnosis for men with heterosexual transmission in particular. For pre-migration infections, median time from arrival to diagnosis was estimated at 0.60 years (95% CrI 0.47–0.83), and an estimated 50.5% of those diagnosed to date were late.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Late HIV diagnosis represents a significant challenge. Estimating time-to-diagnosis distributions may help separate the influence of testing delays from incidence and migration. The burden demonstrated across multiple groups highlights the need for normalization and expansion of HIV testing within and beyond traditional risk groups.</p>\u0000 </section>\u0000 </div>","PeriodicalId":13176,"journal":{"name":"HIV Medicine","volume":"27 11","pages":"1881-1895"},"PeriodicalIF":3.2,"publicationDate":"2026-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/hiv.70311","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149038414","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"HIV-related knowledge and stigma among healthcare workers in Greece: A secondary analysis of a European survey","authors":"Charalampos D. Moschopoulos, Nikos Pantazis, Konstantinos Protopapas, Dimitra Kavatha, Giota Touloumi, Charalampos Gogos, Marios Lazanas, Antonios Papadopoulos","doi":"10.1111/hiv.70306","DOIUrl":"10.1111/hiv.70306","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>HIV-related stigma in healthcare settings remains a barrier to equitable care for people living with HIV. Data on HIV-related knowledge and stigmatizing attitudes among healthcare workers (HCWs) in Greece are limited. This study aimed to describe HIV-related knowledge, stigmatizing attitudes and discriminatory practices among HCWs in Greece and to identify factors associated with higher knowledge and stigma.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We conducted a secondary analysis of the Greek subset of the 2023 ECDC/EACS survey on HIV-related knowledge and stigma among HCWs. HIV knowledge was assessed using three items on undetectable equals untransmittable (‘U=U’), post-exposure prophylaxis (PEP) and pre-exposure prophylaxis (PrEP), combined into a four-level ordinal variable. Stigmatizing attitudes were assessed using an eight-item mean score. Associations with knowledge were examined using proportional-odds ordinal logistic regression, and associations with stigma were assessed using a multivariable linear model.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Among 826 respondents, correct knowledge was reported by 57.9% for ‘U=U’, 59.4% for PEP and 39.0% for PrEP. Nearly half answered no more than one item correctly. Higher knowledge was independently associated with younger age, male gender, doctor role, hospital-based practice and greater occupational contact with people living with HIV. The mean stigma score was 2.1 on a 1–5 scale. Higher stigma scores were independently associated with older age, lower HIV knowledge and absence of prior HIV stigma/discrimination training. Doctors had lower adjusted stigma scores than nurses in pairwise comparisons.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Important gaps in HIV prevention knowledge and persistent stigmatizing attitudes were observed among HCWs in Greece. Findings support structured, decentralized educational and stigma-reduction interventions across healthcare settings.</p>\u0000 </section>\u0000 </div>","PeriodicalId":13176,"journal":{"name":"HIV Medicine","volume":"27 11","pages":"1845-1856"},"PeriodicalIF":3.2,"publicationDate":"2026-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/hiv.70306","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148905768","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
HIV MedicinePub Date : 2026-11-02Epub Date: 2026-07-21DOI: 10.1111/hiv.70285
Victor Oluwafemi Femi-Lawal, Rhoda Fadairo, Joshua Alabi, Christian Tague, Mubarak Mustapha, Chukwuebuka Asogwa, Emmanuel Agboke, Oluwatimilehin Oladapo, Emmanuel Ngwu, Gideon Olajide, Daniel Esanju, John Ibeh, Temidayo Lawrence, Ismail Abdullahi, Marvellous Jesujevwe
{"title":"Assessing the impact, barriers and facilitators of peer-driven interventions on the prevention of mother-to-child transmission of HIV in low- and middle-income countries: A systematic review and meta-analysis","authors":"Victor Oluwafemi Femi-Lawal, Rhoda Fadairo, Joshua Alabi, Christian Tague, Mubarak Mustapha, Chukwuebuka Asogwa, Emmanuel Agboke, Oluwatimilehin Oladapo, Emmanuel Ngwu, Gideon Olajide, Daniel Esanju, John Ibeh, Temidayo Lawrence, Ismail Abdullahi, Marvellous Jesujevwe","doi":"10.1111/hiv.70285","DOIUrl":"10.1111/hiv.70285","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Peer interventions may improve retention across the prevention of mother-to-child transmission (PMTCT) cascade in low- and middle-income countries (LMICs), where poor adherence to antiretroviral therapy (ART) remains a major barrier. This systematic review and meta-analysis evaluated the impact of peer support interventions on PMTCT outcomes to inform scalable strategies.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Following PRISMA guidelines, we searched PubMed, Cochrane Library, Scopus and Google Scholar (2008–2025) using terms including ‘peer mentors,’ ‘PMTCT’ and ‘LMICs.’ Independent reviewers conducted data extraction and quality appraisal using Cochrane risk-of-bias tools. Random-effects meta-analysis was performed in R (v4.4.3), with significance set at <i>p</i> < 0.05. Qualitative findings were thematically synthesized.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Twenty-seven studies (<i>n</i> = 26 431) across 10 countries were included. Peer interventions improved ART adherence at one year (OR: 1.19, 95% CI: 1.05–1.35) and two years (OR: 2.04, 95% CI: 1.58–2.64), PMTCT retention at six weeks postpartum (OR: 2.63, 95% CI: 1.56–4.43), infant uptake of HIV prophylaxis (OR: 2.95, 95% CI: 1.90–4.59), early infant diagnosis (OR: 1.64, 95% CI: 1.01–2.67) and viral load testing (OR: 1.21, 95% CI: 1.07–1.38). No significant effects were observed for ART initiation, PMTCT retention at 12 months or HIV status disclosure. Most studies (75%) reported improved exclusive breastfeeding. Barriers included stigma, inadequate mentor training, logistical and economic constraints and poor male involvement; facilitators included training, incentives and community trust.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Peer interventions improve adherence, infant prophylaxis and retention but have limited effects on viral suppression and disclosure. Addressing stigma, strengthening health systems and enhancing male engagement may optimize impact.</p>\u0000 </section>\u0000 </div>","PeriodicalId":13176,"journal":{"name":"HIV Medicine","volume":"27 11","pages":"1736-1752"},"PeriodicalIF":3.2,"publicationDate":"2026-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148535768","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Medication burden and prescribing quality in older people living with HIV: Associations with quality of life","authors":"Abdulkadir Sonkaya, Nurgül Ceran, Seniha Şenbayrak, Asuman Inan, Serpil Erol, Recep Balik, Vahibe Aydin Sarikaya","doi":"10.1111/hiv.70301","DOIUrl":"10.1111/hiv.70301","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>To determine the prevalence of polypharmacy, drug–drug interactions (DDIs), potential prescribing omissions (PPOs) and potentially inappropriate medications (PIMs) among people living with Human Immunodeficiency Virus (HIV) aged ≥50 years and to evaluate their association with quality of life.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>This cross-sectional analytical study was conducted between March and May 2025 at a tertiary infectious disease clinic. A total of 141 people living with HIV aged ≥50 years who were receiving antiretroviral therapy (ART) and under active follow-up were included. DDIs were assessed using the Liverpool HIV Drug Interactions database, while PPOs and PIMs were evaluated using the TIME-to-START and TIME-to-STOP criteria. Quality of life was assessed using the PozQoL scale.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Polypharmacy was identified in 42 participants (29.8%) and DDIs in 22 (15.6%). Although PPOs were initially identified in all participants according to TIME-to-START criteria, this was largely driven by vaccination-related items. Vaccination-related items were excluded when evaluating the association between PPOs and quality of life, and the prevalence of PPOs decreased to 32.6%. PIMs were detected in 16.3%. Polypharmacy was associated with low quality of life in the health concern domain (OR 3.52, 95% CI 1.34–9.27). DDIs were associated with low overall (OR 7.65, 95% CI 2.01–29.07) and psychological quality of life (OR 14.55, 95% CI 3.45–61.37). PPOs were associated with low psychological (OR 10.67, 95% CI 2.80–40.68) and health concern domains (OR 3.19, 95% CI 1.27–8.05).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Medication-related problems were common among older people living with HIV. Polypharmacy, DDIs and PPOs were associated with impaired quality of life, highlighting the need for structured medication review and multidisciplinary care.</p>\u0000 </section>\u0000 </div>","PeriodicalId":13176,"journal":{"name":"HIV Medicine","volume":"27 11","pages":"1802-1813"},"PeriodicalIF":3.2,"publicationDate":"2026-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148827914","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
HIV MedicinePub Date : 2026-11-02Epub Date: 2026-09-11DOI: 10.1111/hiv.70291
Fabio Antonino Ranzani, Chiara Montrucchio, Ilario Ferrocino, Donatella Penoncelli, Ilaria Cavecchia, Cristina Tettoni, Micol Ferrara, Andrea Pezzana, Alice Palermiti, Alessandro Lazzaro, Stefano Bonora, Giovanni DiPerri, Andrea Calcagno
{"title":"The effect of a tailored dietary intervention on serum biomarkers and faecal microbiome composition in people with HIV at risk of cardiovascular disease","authors":"Fabio Antonino Ranzani, Chiara Montrucchio, Ilario Ferrocino, Donatella Penoncelli, Ilaria Cavecchia, Cristina Tettoni, Micol Ferrara, Andrea Pezzana, Alice Palermiti, Alessandro Lazzaro, Stefano Bonora, Giovanni DiPerri, Andrea Calcagno","doi":"10.1111/hiv.70291","DOIUrl":"10.1111/hiv.70291","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>People with HIV (PWH) are at higher risk of cardiovascular disease (CVD) despite spontaneous or antiretroviral therapy-induced long-lasting suppressed viremia. Traditional and HIV-specific factors have been identified, but CVD incidence and mortality remain high. A microbiome is a community of germs living close to their human host, and bacterial dysbiosis is associated with atherosclerosis and chronic non-communicable disease development.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We conducted a pilot study designed to analyze the effect of tailored diet intervention on body mass index (BMI), metabolic features and microbiota composition in PWH with suppressed HIV viremia (HIV RNA <50 copies/mL) under combination antiretroviral treatment. Biomarkers and parameters were measured at baseline and 6 months (M6) after.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Ten male participants were enrolled. The median age was 60.5 years (54–69) and the 10-year CV risk was 11.7% (7.2–21.2). CD4+ T lymphocyte count was 568 cells/mm<sup>3</sup> (398–625). Approximately 75% of participants declared to be adherent to the given dietary recommendations. Participants showed reduced amounts of food intake (<i>p</i> = 0.022) and, specifically, of saturated fat (<i>p</i> = 0.007) and cholesterol (<i>p</i> = 0.011). At M6, most metabolic and inflammatory parameters remained stable. TMAO concentrations were higher at M6 than at baseline (157 vs. 129 ng/mL, <i>p</i> = 0.050). Microbiota alpha and beta diversity did not change over time: yet we observed a significant reduction of <i>Firmicutes</i> (<i>p</i> = 0.047) and an increase in <i>Proteobacteria</i> (<i>p</i> = 0.028) relative abundance at M6.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>In this pilot study assessing a tailored dietary intervention in high CV-risk PWH, we observed stable metabolic and inflammatory parameters and an unexpected increase in TMAO levels at 6 months. Microbiome composition was marginally affected, and active interventions are probably needed to elicit significant changes over time.</p>\u0000 </section>\u0000 </div>","PeriodicalId":13176,"journal":{"name":"HIV Medicine","volume":"27 11","pages":"1778-1789"},"PeriodicalIF":3.2,"publicationDate":"2026-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148929601","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
HIV MedicinePub Date : 2026-11-02Epub Date: 2026-09-14DOI: 10.1111/hiv.70308
Daniela Piacentini, Lavinia Cosimi, Antonella Castagna, Annamaria Cattelan, Andrea Antinori, Vincenzo Esposito, Nicoletta Frattini, Vania Giacomet, Giuseppina Giupponi, Sergio Lo Caputo, Paolo Meli, Cristina Mussini, Giuseppe Nunnari, Saverio G. Parisi, Stefano Rusconi, Massimiliano Lanzafame
{"title":"Clinical management of pregnancy, delivery and breastfeeding in women living with HIV in Italy: A survey of participating infectious diseases centres","authors":"Daniela Piacentini, Lavinia Cosimi, Antonella Castagna, Annamaria Cattelan, Andrea Antinori, Vincenzo Esposito, Nicoletta Frattini, Vania Giacomet, Giuseppina Giupponi, Sergio Lo Caputo, Paolo Meli, Cristina Mussini, Giuseppe Nunnari, Saverio G. Parisi, Stefano Rusconi, Massimiliano Lanzafame","doi":"10.1111/hiv.70308","DOIUrl":"10.1111/hiv.70308","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Management of pregnancy in women living with HIV is evolving in high-income settings, with increasing attention to infant feeding under sustained virological suppression. Real-world data from Europe remain limited. This study aimed to describe self-reported organizational models and routine approaches to clinical care in participating Italian infectious diseases centres.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>An online survey was conducted among Italian infectious diseases centres via the Italian Cohort of Antiretroviral-Naïve Patients (ICAR) and the Italian Society of Infectious and Tropical Diseases (SIMIT) networks. The questionnaire explored organizational models, ART management, delivery, neonatal prophylaxis and breastfeeding. Data were analysed descriptively.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Forty-one centres from 15 regions participated, reporting approximately 300 women living with HIV pregnancies in 2024. Most centres (78.0%) had local pregnancy protocols, typically involving multidisciplinary teams. Reported practices varied across several aspects of care, including ART management during pregnancy, obstetric follow-up, mode of delivery and neonatal prophylaxis. Elective caesarean section (CS) was recommended irrespective of virological status in 9.8% of centres; routine intrapartum intravenous zidovudine was reported in 17.1%. Neonatal zidovudine prophylaxis was used by 90.2% of centres (duration: 2–6 weeks). Requests for breastfeeding were reported by 53.7% of centres; eight centres supported breastfeeding under strict clinical conditions, involving 36 women.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>This survey highlights substantial heterogeneity in self-reported organizational models and reported practices among participating Italian infectious diseases centres caring for pregnant women living with HIV. Although direct clinical experience with supported breastfeeding remains limited, the findings support the development of harmonized, evidence-based guidance to promote equitable multidisciplinary care and informed shared decision-making and provide a framework for greater consistency in pregnancy and infant feeding management.</p>\u0000 </section>\u0000 </div>","PeriodicalId":13176,"journal":{"name":"HIV Medicine","volume":"27 11","pages":"1870-1880"},"PeriodicalIF":3.2,"publicationDate":"2026-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148967921","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
HIV MedicinePub Date : 2026-11-02Epub Date: 2026-09-17DOI: 10.1111/hiv.70310
Fátima Brañas, M. José Galindo, Miguel Torralba, Antonio Antela, María Luisa Montes, M. Jesús Bustinduy, Noemí Cabello, Alfonso Cabello, Margarita Ramírez, Pablo Ryan, Iñigo Bustingorri, Isabel Machuca, Matilde Sánchez-Conde
{"title":"Quality of life among older adults with HIV after switching to bictegravir-based three-drug or dolutegravir-based two-drug regimens","authors":"Fátima Brañas, M. José Galindo, Miguel Torralba, Antonio Antela, María Luisa Montes, M. Jesús Bustinduy, Noemí Cabello, Alfonso Cabello, Margarita Ramírez, Pablo Ryan, Iñigo Bustingorri, Isabel Machuca, Matilde Sánchez-Conde","doi":"10.1111/hiv.70310","DOIUrl":"10.1111/hiv.70310","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Data on adults aged ≥60 years with HIV remain limited, despite their increasing representation in clinical practice. We evaluated whether age ≥60 years was associated with reasons for treatment switch, quality of life (QoL) and clinical outcomes among adults with HIV switching antiretroviral therapy in routine care.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We performed a cross-sectional analysis of prospectively collected data from a real-world cohort established in 2018, including adults with HIV aged ≥50 years who switched to bictegravir-based three-drug regimens (BIC 3DR) or dolutegravir-based two-drug regimens (DTG 2DR). Participants were stratified by age (≥60 vs. <60 years). Outcomes included reasons for treatment switch, incident comorbidity and self-reported QoL. QoL was analysed as both ordinal and dichotomous (favourable vs. non-favourable). Multivariable analyses were adjusted for treatment strategy, sex and HIV acquisition route.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The distribution of reasons for treatment switch differed by age within the DTG 2DR group (<i>p</i> = 0.005), but not within the BIC 3DR group. In the DTG 2DR group, toxicity or adverse events accounted for 5.6% of switches among participants aged <60 years and 21.7% among those aged ≥60 years (<i>p</i> = 0.008), with a significant age-group-by-treatment-strategy interaction (<i>p</i> = 0.001). Age ≥60 years was independently associated with higher odds of favourable QoL (adjusted odds ratio [OR] 2.88, 95% confidence interval [CI] 1.15–7.24), with no interaction by treatment. No significant differences were observed in incident hypertension, type 2 diabetes mellitus or dyslipidemia in time-to-event analyses.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Among adults with HIV switching antiretroviral therapy, age ≥60 years was associated with differences in the distribution of reasons for treatment switch and with better perceived QoL, but not with differences in clinical outcomes.</p>\u0000 </section>\u0000 </div>","PeriodicalId":13176,"journal":{"name":"HIV Medicine","volume":"27 11","pages":"1896-1902"},"PeriodicalIF":3.2,"publicationDate":"2026-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148989957","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
HIV MedicinePub Date : 2026-11-02DOI: 10.1111/hiv.70338
Rubén Corral-San Miguel, Cristina Tomás-Jiménez, Eva García-Villalba, Salvador Valero-Cifuentes, Jose Miguel Gómez-Verdú, Antonia Alcaraz-García, Rodrigo Martínez-Rodríguez, María Dolores Hernández-Lorente, Román González-Hipólito, Elena Guijarro-Westerneyer, Ángeles Muñóz-Pérez, Enrique Bernal-Morell
{"title":"Prevalence of metabolic syndrome and classification performance of triglyceride-glucose-derived indices in people living with HIV in Spain.","authors":"Rubén Corral-San Miguel, Cristina Tomás-Jiménez, Eva García-Villalba, Salvador Valero-Cifuentes, Jose Miguel Gómez-Verdú, Antonia Alcaraz-García, Rodrigo Martínez-Rodríguez, María Dolores Hernández-Lorente, Román González-Hipólito, Elena Guijarro-Westerneyer, Ángeles Muñóz-Pérez, Enrique Bernal-Morell","doi":"10.1111/hiv.70338","DOIUrl":"https://doi.org/10.1111/hiv.70338","url":null,"abstract":"<p><strong>Objectives: </strong>Estimate the prevalence and predominant phenotypic patterns of metabolic syndrome (MetS) in people living with HIV receiving contemporary antiretroviral therapy (ART) in southeastern Spain, identify independently associated factors and evaluate the classification performance and clinical utility of triglyceride-glucose (TyG)-derived indices relative to a multivariable logistic regression (MLR) model.</p><p><strong>Methods: </strong>Cross-sectional study of 287 people living with HIV on stable ART for ≥6 months. MetS was defined by National Cholesterol Education Program Adult Treatment Panel III (NCEP-ATP III) criteria. MLR identified factors independently associated with MetS. Receiver operating characteristic (ROC), DeLong pairwise comparisons and decision curve analysis (DCA) compared the TyG, TyG-waist circumference (TyG-WC) and TyG-waist-to-height ratio (TyG-WHtR) against the MLR model.</p><p><strong>Results: </strong>MetS prevalence was 30.3% (95% CI 25.1%-36.0%), with hyperglycaemia, hypertension and increased waist circumference (G-B-W) as the predominant three-component cluster (16.1%, adjusted residual 3.67). Independently associated factors were body mass index (BMI) (aOR 1.44; 95% CI 1.28-1.64; p < 0.001), age >50 years (aOR 5.02; 95% CI 1.94-13.03; p = 0.001) and lower CD4 nadir (aOR 0.997; 95% CI 0.995-1.000; p = 0.032); neither ART regimen nor prior protease inhibitor (PI) exposure was associated. AUCs were 0.876 for MLR, 0.864 for TyG, 0.901 for TyG-WC and 0.912 for TyG-WHtR (all p < 0.001) without significant pairwise differences. DCA showed net benefit for TyG-WHtR comparable to the MLR model.</p><p><strong>Conclusions: </strong>MetS affects nearly one-third of people living with HIV on contemporary ART in southeastern Spain, driven primarily by BMI, advanced age and lower nadir CD4, with a predominant G-B-W phenotype. TyG-WHtR offers classification performance comparable to a full multivariable model using routine parameters, supporting its use as a low-burden MetS screening tool in HIV care.</p>","PeriodicalId":13176,"journal":{"name":"HIV Medicine","volume":" ","pages":""},"PeriodicalIF":3.2,"publicationDate":"2026-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149320727","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}